Evolution of kidney care: Past lessons, present innovation towards a hopeful future

Time of India

2 days ago

Evolution of kidney care Past lessons, present innovation towards a hopeful future
Kidney disease has long stood as a silent threat—one that quietly erodes health until its effects are irreversible. Among its many forms, chronic kidney failure remains particularly severe.
It's important to reflect on how far we've come, the challenges that remain, and the promise the future holds.
The past: From hopelessness to hope
A century ago, the diagnosis of chronic kidney failure was tantamount to a death sentence. There were no effective treatments, no dialysis, and little understanding of disease progression. Early attempts at dialysis in the 1920s were primitive—massive and complex machines with limited impact and frequent complications.
Most patients slipped away quietly, undiagnosed and untreated.
The 1950s brought a glimmer of hope. The first kidney transplants—fraught with the dangers of immune rejection—eventually gave way to success, beginning with a landmark 1954 transplant between identical twins. Over time, medical science developed ways to tame the immune system with anti-rejection medications, transforming kidney transplantation from an experimental procedure into a viable, lifesaving therapy.
India reached its own milestone in 1971, with the first successful transplant performed at Christian Medical College, Vellore, ushering in a new era of domestic nephrology care.
The present: Precision, progress, and accessibility
Today, the field of nephrology is a testament to scientific progress. Chronic kidney disease (CKD) no longer hides in the shadows; awareness is growing, diagnostics are improving, and treatments are more accessible than ever.
In India alone, an estimated 10–12% of the population lives with some form of kidney disease.
The root cause of this- Diabetes—a condition affecting over 77 million Indians, with nearly half already showing signs of kidney damage.
Advancements in diagnostic tools—from routine ultrasounds to precise kidney biopsies—allow for earlier detection and intervention. Pharmaceutical breakthroughs, including SGLT2 inhibitors, ACE inhibitors, ARBs, and newer agents like finerenone, are helping clinicians slow the progression of disease and safeguard kidney function.
When kidney failure becomes advanced, life does not have to stop. Innovations in dialysis—whether hospital-based or increasingly at home—offer patients a chance at stability and quality of life. Transplantation, once considered a last resort, now stands as a symbol of medical triumph. With decades of research yielding better immunosuppressive drugs and surgical precision, transplant survival rates have improved significantly.
From laparoscopic procedures to more refined HLA-matching protocols, the outcomes today are better than ever.
Even procedures once thought impossible—transplants across incompatible blood types, combined liver-kidney operations, and pancreas-kidney transplants for diabetic patients—are becoming increasingly common.
The future: Toward artificial organs and regenerative breakthroughs
Looking forward, the horizon of kidney care is expanding with promise. Scientists are pushing boundaries with novel therapeutics aimed at halting kidney decline earlier and more effectively than ever before.
Recently, Zydus Lifesciences also conducted a campaign #LifeKaFilter that revolves around the importance of kidney health.
The campaign highlighted various issues including how dialysis and transplants are lifesavers, but prevention is always better. Also, highlighted the government schemes that can ease the burden of kidney treatment costs.
Researchers are exploring portable and wearable dialysis devices, which may soon enable patients to achieve even greater independence, offering freedom from the rigid schedules and physical toll of traditional dialysis.
Perhaps the most revolutionary prospect lies in xenotransplantation—transplanting genetically engineered animal kidneys, typically from pigs, into humans. Though still in the realm of clinical trials, these experiments hint at a future where organ shortages may no longer be the bottleneck they are today.
We are entering a golden era in nephrology, where technology, science, and access are converging to make what was once a life-threatening disease highly manageable, even curable.
Author:
Dr. Siddharth Mavani,
Director, Nephrology and Kidney Transplant,
Marengo CIMS Hospital, Ahmedabad
The above is non-editorial content and TIL does not guarantee, vouch or endorse any of it. Please take all steps necessary to ascertain that any information and content provided is correct, updated, and verified.
Stay informed with the latest
business
news, updates on
bank holidays
and
public holidays
.
AI Masterclass for Students. Upskill Young Ones Today!– Join Now